Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals … (NCT05645640) | Clinical Trial Compass
CompletedNot Applicable
Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk
China4,533 participantsStarted 2023-03-16
Plain-language summary
The China PEACE SMARTER trial is a cluster ramdomized trial aiming to assess the effectiveness of village doctor-led tailored health management on risk reduction of high-risk individuals for cardiovascular disease.
Who can participate
Age range35 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 35 or above;
* High CVD risk which defined as 10-year ASCVD risk ≥10% based on China-PAR prediction model;
* Ownership of a smart phone and being able to use apps;
* Being contracted with the local family doctor (village doctor);
* Willing to participate and able to sign informed consent.
Exclusion Criteria:
* CVD history, including myocardial infarction (MI), stroke, heart failure, severe arrhythmia, or peripheral artery disease, or having received percutaneous coronary intervention (PCI) or coronary artery by-pass grafting operation (CABG);
* Severe illnesses, such as cancer, or severe hepatic and renal dysfunction;
* Women during pregnancy, lactation, or plan to have children in the next year;
* Having problems in cognition or communication, or limited daily activities.
What they're measuring
1
10-year ASCVD risk score
Timeframe: 12 months
Trial details
NCT IDNCT05645640
SponsorChina National Center for Cardiovascular Diseases